Utah Medical Products Inc
UTMD
View Detailed Chart
61.640USD
-1.220-1.94%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
197.49MMarket Cap
17.40P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-1.94%
5 Days
+0.95%
1 Month
+7.69%
6 Months
+9.58%
Year to Date
+10.15%
1 Year
+2.90%
View Detailed Chart
TradingKey Stock Score of Utah Medical Products Inc
Currency: USD Updated: 2026-02-06Key Insights
Utah Medical Products Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 100 out of 205 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Utah Medical Products Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Utah Medical Products Inc Highlights
StrengthsRisks
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Growing
The company is in a growing phase, with the latest annual income totaling USD 40.90M.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 30.19%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 30.19%.
Fairly Valued
The company’s latest PE is 17.40, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 2.28M shares, decreasing 20.11% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 175.97K shares of this stock.
Analyst Rating
Based on
0
analysts
--
Current Rating
--
Target Price
--
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Utah Medical Products Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Utah Medical Products Inc Info
Utah Medical Products, Inc. develops, manufactures and markets a broad range of disposable and reusable specialty medical devices. The Company has a particular interest in healthcare for women and their babies. The Company’s broad range of products includes those used in critical care areas and the labor and delivery departments of hospitals, as well as outpatient clinics and physicians’ offices. Its products include BT-CATH, CVX-RIPE, AROM-COT, MUC-X, CORDGUARD, DISPOSA-HOOD, DELTRAN PLUS, GESCO, PICC-NATE, LETZ System, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, LUMIN, and BioPharm HP-PRT, among others. BT-CATH is a patented uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device. The Company produces medical devices for blood pressure monitoring and blood management, electrosurgery, labor and delivery, neonatal intensive care, urological care and women’s pelvic health.
Ticker SymbolUTMD
CompanyUtah Medical Products Inc
CEOCornwell (Kevin L)
Websitehttp://www.utahmed.com
Related Instruments
+2.98%
+0.07%
+1.60%
+2.48%
+0.31%
-1.14%
-0.05%
-2.35%
-1.78%
+2.65%
+2.59%
+2.03%
+2.01%
+2.38%
+1.74%
+0.16%
+0.78%
+1.72%
+0.59%
-2.02%Popular Symbols
278.120
+2.210 (+0.80%)
185.410
+13.530 (+7.87%)
68556.420
-1413.710 (-2.02%)
282.580
+22.390 (+8.61%)
2016.520
-35.210 (-1.72%)
411.110
+13.900 (+3.50%)
4952.980
+142.360 (+2.96%)
63.303
+0.206 (+0.33%)
1.182
+0.004 (+0.35%)
157.098
+0.057 (+0.04%)
